Considering that cancer tissues possess endocycling cells at a high frequency and that endocycle is considered crucial for tumorigenesis [6–8], elucidating the role of TRiC in MES and endocycle progression is a fundamental step to revealing TRiC-mediated control of oncogenesis. This evidence concerns the gene MARVELD2 and cancer.